Hutch News

Hutch News

Stories tagged 'africa'

Closing the breast cancer divide in sub-Saharan Africa

Clinical trial in Uganda will test alternative diagnostic tool and oral chemotherapy, study genetic differences

Aug. 15, 2017 | By Mary Engel / Fred Hutch News Service

Researchers from Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute are launching a clinical study in the Ugandan capital Kampala that could change the way breast cancer in sub-Saharan Africa is diagnosed and treated.

View story >


Good News at Fred Hutch

Dr. Amanda Paulovich wins proteomic sciences award; Dr. David Coffey receives ASH research training award; endowed chair named in honor of the late Dr. Stephen Petersdorf

Aug. 13, 2015 | By Fred Hutch staff

Dr. Amanda Paulovich wins proteomic sciences award; Dr. David Coffey receives ASH research training award; endowed chair named in honor of the late Dr. Stephen Petersdorf

View story >


Fred Hutch-affiliated clinical researcher receives South Africa's highest civilian award

HIV Vaccine Trials Network's Africa Programs Director Glenda Gray lauded for lifesaving HIV/AIDS work

May 7, 2013 | By Colleen Steelquist

View story >


Six-month drug regimen cuts HIV risk for breastfeeding infants

SCHARP data shows longer nevirapine treatment reduces infection by half for babies with HIV-infected mothers, 75 percent for infants of untreated moms

March 14, 2011

Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented March 2 at the Retroviruses and Opportunistic Infections conference in Boston.

View story >


American Society for Microbiology lauds Blish

HIV research garners early career award

Sept. 20, 2010

The Fred Hutchinson Cancer Research Center’s Dr. Catherine Blish is the recipient of an Interscience Conference on Antimicrobial Agents and Chemotherapy Young Investigator Award from the American Society for Microbiology for her work elucidating the role of neutralizing antibodies in HIV transmission.

View story >


Study shows ART lowers HIV transmission

Antiretroviral therapy associated with 92 percent decreased risk of HIV transmission among HIV-1 discordant couples in large, multinational study

June 1, 2010

Research led by Dr. Deborah Donnell of the Vaccine and Infectious Disease Institute at the Fred Hutchinson Cancer Research Center has found that treating HIV-infected persons with antiretroviral therapy (ART) reduces HIV transmission to their sexual partners by more than 90 percent.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.